HerediGENE® is an assay that fully analyzes a panel of 43 genes, including BRCA Gene mutations.
These 43 genes are associated with increased risk of developing breast, ovarian, colon and other hereditary cancer syndromes.
The test identifies those family members at risk of developing cancer who can benefit from risk reduction management.
It detects gene mutations (including the brca gene mutations – BRCA1 , BRCA2 Genes) that may pass increased cancer risk to your children.
It identifies the family members that do not carry the pathogenic mutation that was detected in the family, relieving them of the stress of developing hereditary cancer syndromes or foregoing unnecessary interventions.